首页 正文

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs

{{output}}
Background: Several drugs are available for the preventive treatment of both episodic and chronic migraine. The choice of which therapy to initiate first, second, or third is not straightforward and is based on multiple factors, ... ...